Does Late-Onset Huntington Disease Represent a Distinct Symptomatic Picture? Evidence for a Selective Deficit in Executive Function and Emotion Recognition, in the Absence of Behavioral and Psychiatric Disorders
DOI:
https://doi.org/10.6000/2292-2598.2019.07.04.7Keywords:
Huntington's chorea, Affective Processing, CognitionAbstract
Huntington Disease (HD) is an autosomal-dominant, neurodegenerative disorder, including motor, cognitive, emotional and behavioral symptoms. Motor symptoms used to set the clinical onset, typically emerge in the middle age. Here, we describe the case of a patient, who received a genetic diagnosis at 75 years and developed motor symptoms at 80. The Patient shows severe motor symptoms in the absence of personality changes or psychiatric disorders typically observed in HD. For what attain neuropsychological profile, it results unaltered apart from a specific deficit in emotion recognition and general slowness on executive functioning tasks, reflecting a specific trade-off between accuracy and rate of performances, that is a selective impairment in fine-tuning of resources. Both of these deficits in the Patient could be ascribable to the frontostriatal atrophy, evidenced by Computed Tomography. While deficit in emotion recognition is a well-known symptom in HD, a deficit in fine-tuning of resources regards a specific aspect of executive function. The ability of fine-tuning resources is the latest step in the development of executive functions, and it could be also the first level to be impaired in HD. We proposed that deficit in fine-tuning of resources could be the core of the neuropsychological deficit in late-onset HD.
References
Walker FO. Huntington's disease. The Lancet 2007; 218-228. https://doi.org/10.1016/S0140-6736(07)60111-1 DOI: https://doi.org/10.1016/S0140-6736(07)60111-1
Rosenblatt A, Brinkman RR, Liang KY, et al. Familial influence on age of onset among siblings with Huntington disease. American Journal of Medical Genetics Neuropsychiatric Genetics 2001; 105(5): 399-403. https://doi.org/10.1002/ajmg.1400 DOI: https://doi.org/10.1002/ajmg.1400.abs
Rosenblatt A, Liang KY, Zhou H, et al. The association of CAG repeat length with clinical progression in Huntington disease. Neurology 2006; 66(7): 1016-1020. https://doi.org/10.1212/01.wnl.0000204230.16619.d9 DOI: https://doi.org/10.1212/01.wnl.0000204230.16619.d9
Sipilä JOT, Kauko T, Päivärinta M, Majamaa, K. Comparison of mid-age-onset and late-onset Huntington’s disease in Finnish patients. J Neurol 2017; 264(10): 2095-2100. https://doi.org/10.1007/s00415-017-8600-2 DOI: https://doi.org/10.1007/s00415-017-8600-2
Kremer B, Squitieri F, Telenius H, et al. Molecular analysis of late-onset Huntington's disease. Journal of Medical Genetics 1993; 30(12): 991-995. https://doi.org/10.1136/jmg.30.12.991 DOI: https://doi.org/10.1136/jmg.30.12.991
Snowden JS. The Neuropsychology of Huntington’s Disease. Archives of Clinical Neuropsychology 2017; 32: 876-887. https://doi.org/10.1093/arclin/acx086 DOI: https://doi.org/10.1093/arclin/acx086
Groen JL, de Bie RMA, Foncke EMJ, Roos RAC, Leenders KL, Tijssen MAJ. Late-onset Huntington disease with intermediate CAG repeats: true or false? Journal of Neurology, Neurosurgery & Psychiatry 2010; 81(2): 228-230. https://doi.org/10.1136/jnnp.2008.170902 DOI: https://doi.org/10.1136/jnnp.2008.170902
Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234-238. https://doi.org/10.1038/306234a0 DOI: https://doi.org/10.1038/306234a0
Claes S, Van Zand K, Legius E, et al. Correlations between triplet repeat expansions and clinical features in Huntington's disease. Arch Neurol 1995; 52: 749-753. https://doi.org/10.1001/archneur.1995.00540320021009 DOI: https://doi.org/10.1001/archneur.1995.00540320021009
Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington’s disease. Ann Neurol 1996; 39: 132-136. https://doi.org/10.1002/ana.410390120 DOI: https://doi.org/10.1002/ana.410390120
Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol 1997; 41: 689-692. https://doi.org/10.1002/ana.410410521 DOI: https://doi.org/10.1002/ana.410410521
Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996; 46: 527-531. https://doi.org/10.1212/WNL.46.2.527 DOI: https://doi.org/10.1212/WNL.46.2.527
Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington’s disease. Ann Neurol 1994; 36: 630-635. https://doi.org/10.1002/ana.410360412 DOI: https://doi.org/10.1002/ana.410360412
Myers RH, Sax DS, Schoenfeld M, et al. Late-onset of Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry 1985; 48(6): 530-534. https://doi.org/10.1136/jnnp.48.6.530 DOI: https://doi.org/10.1136/jnnp.48.6.530
Lipe H, Bird T. Late-onset Huntington Disease: Clinical and genetic characteristics of 34 cases. Journal of the Neurological Sciences 2009; 276(1-2): 159-162. https://doi.org/10.1016/j.jns.2008.09.029 DOI: https://doi.org/10.1016/j.jns.2008.09.029
Koutsis G, Karadima G, Kladi A, Panas M. Late-onset Huntington’s disease: Diagnostic and prognostic considerations. Parkinsonism and Related Disorders 2014; 20(7): 726-30. https://doi.org/10.1016/j.parkreldis.2014.03.017 DOI: https://doi.org/10.1016/j.parkreldis.2014.03.017
Basso A, Capitani E, Laiacona M. Raven’s Coloured Progressive Matrices: Normative Values on 305 Adult Normal Controls. Functional Neurology 1987; 2: 189-194.
Mondini S, Mapelli D, Vestri A, Bisiacchi PS. Esame Neuropsicologico Breve (ENB). Una batteria di test per lo screening neuropsicologico. Milano: Raffaello Cortina Editore 2003.
Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. [Italian normative values and standardization of neuropsychological tests]. Italian Journal of Neurological Sciences 1987; 6(Suppl. 8), 1-20.
Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E. A normative study on visual reaction times and two Stroop colour-word tests. The Italian Journal of Neurological Sciences 1998; 19(3): 161-170. https://doi.org/10.1007/BF00831566 DOI: https://doi.org/10.1007/BF00831566
Capitani E, Laiacona M, Basso A. Phonetically cued word-fluency, gender differences and aging: a reappraisal. Cortex 1998; 34(5): 779-783. https://doi.org/10.1016/S0010-9452(08)70781-0 DOI: https://doi.org/10.1016/S0010-9452(08)70781-0
Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G. Tre test clinici di memoria a lungo termine. Taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria 1986a; 47(2): 278-96.
Amodio P, Wenin H, Del Piccolo F, et al. Variability of Trail Making Test, Symbol Digit Test and Line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clinical and Experimental Research 2002; 14(2): 117-131. https://doi.org/10.1007/BF03324425 DOI: https://doi.org/10.1007/BF03324425
Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail Making Test: normative values from 287 normal adult and controls. The Italian Journal of Neurological Sciences 1996; 17(4): 305-309. https://doi.org/10.1007/BF01997792 DOI: https://doi.org/10.1007/BF01997792
Wilson B, Cockburn J, Halligan PW. Behavioral Inattention Test. Titchfield, Hants: Thames Valley Test Company 1987.
Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G. Tre test clinici di memoria a lungo termine. Taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria 1986b; 47(4): 477-506.
De Renzi E. The Token Test and the Reporter’s Test: a measure of verbal input and a measure of verbal output. In: a cura di Sarno MT, Hook O. Aphasia: assessment and treatment. Stockholm: Almqvist e Wiksell; New York: Masson 1980.
Martino AA, Pizzamiglio L, Razzano C. A new version of the “token test” for aphasics: a concrete object form. J Commun Disord 1976; 9(1): 1-5. https://doi.org/10.1016/0021-9924(76)90025-3 DOI: https://doi.org/10.1016/0021-9924(76)90025-3
Hennenlotter A, Schroeder U, Erhard P, et al. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 2004; 127(Pt 6): 1446-1453. https://doi.org/10.1093/brain/awh165 DOI: https://doi.org/10.1093/brain/awh165
Ekman P, Friesen WV. Facial Action Coding System: A Technique for the Measurement of Facial Movement. Consulting Psychologists Press, Palo Alto 1978. https://doi.org/10.1037/t27734-000 DOI: https://doi.org/10.1037/t27734-000
Ekman P, Friesen WV, Ellsworth P. Emotion in the Human Face. Elmsford, N.Y.: Pergamon Publishing Co 1972.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory. Neurology 1994; 83: 620-627. https://doi.org/10.1037/t28621-000 DOI: https://doi.org/10.1037/t28621-000
Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ. Altered brain mechanism of emotion processing in pre-manifest Huntington’s Disease. Brain 2012; 135(Pt 4): 1165-1179. https://doi.org/10.1093/brain/aws024 DOI: https://doi.org/10.1093/brain/aws024
Anderson P. Assessment of Development of Executive Function (EF) during Childhood. Child Neuropsychology 2002; 8(2): 71-82. https://doi.org/10.1076/chin.8.2.71.8724 DOI: https://doi.org/10.1076/chin.8.2.71.8724
Julien CL, Thompson JC, Wild S, et al. Psychiatric disorder in preclinical HD. Journal of Neurology, Neurosurgery & Psychiatry 2007; 78(9): 939-943. https://doi.org/10.1136/jnnp.2006.103309 DOI: https://doi.org/10.1136/jnnp.2006.103309
Squitieri F, Cannella M, Giallonardo P, Maglione V, Mariotti C, Hayden MR. Onset and pre-onset studies to define the Huntington’s disease natural history. Brain Research Bulletin 2001; 56(3): 233-238. https://doi.org/10.1016/S0361-9230(01)00648-7 DOI: https://doi.org/10.1016/S0361-9230(01)00648-7
Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry 2001; 71(3): 310-314. https://doi.org/10.1136/jnnp.71.3.310 DOI: https://doi.org/10.1136/jnnp.71.3.310
Stout JC, Paulsen JS, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011; 25(1): 1-14. https://doi.org/10.1037/a0020937 DOI: https://doi.org/10.1037/a0020937
Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation. J Neurol 2004; 251(8): 935-942. https://doi.org/10.1007/s00415-004-0461-9 DOI: https://doi.org/10.1007/s00415-004-0461-9
Gómez-Tortosa E, del Barrio A, Garcia Ruiz PJ, et al. Severity of cognitive impairment in juvenile and late-onset Huntington disease. Archives of Neurology 1998; 55(6): 835-843. https://doi.org/10.1001/archneur.55.6.835 DOI: https://doi.org/10.1001/archneur.55.6.835
Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198. https://doi.org/10.1016/0022-3956(75)90026-6 DOI: https://doi.org/10.1016/0022-3956(75)90026-6
Downloads
Published
How to Cite
Issue
Section
